High aldehyde dehydrogenase activity at diagnosis predicts relapse in patients with t(8;21) acute myeloid leukemia

High aldehyde dehydrogenase activity at diagnosis predicts relapse in patients with t(8;21) acute myeloid leukemia

Abstract Acute myeloid leukemia (AML) with t(8;21) is a heterogeneous disease. Although the detection of minimal residual disease (MRD), which is indicated by RUNX1‐RUNX1T1 transcript levels, plays a key role in directing treatment, risk stratification needs to be improved, and other markers need to...

Full description

Bibliographic Details
Main Authors: Lu Yang, Wen‐Min Chen, Feng‐Ting Dao, Yan‐Huan Zhang, Ya‐Zhe Wang, Yan Chang, Yan‐Rong Liu, Qian Jiang, Xiao‐Hui Zhang, Kai‐Yan Liu, Xiao‐Jun Huang, Ya‐Zhen Qin
Format: Article
Language:English
Published: Wiley 2019-09-01
Series:Cancer Medicine
Subjects:
aldehyde dehydrogenase
flow cytometry
minimal residual disease
relapse
RUNX1‐RUNX1T1
t(8;21) acute myeloid leukemia
Online Access:https://doi.org/10.1002/cam4.2422

Internet

https://doi.org/10.1002/cam4.2422

Similar Items